2.97

1.02% +0.03

After Hours: 2.97

Conduit Pharmaceuticals Inc (CDT)

Overview News Price History Why CDT Down? Discussions Forecast

Conduit Pharmaceuticals Inc stock is currently priced at $2.97, with a 24-hour trading volume of 26,863. It has seen a +1.02% increased in the last 24 hours and a +0.00% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $2.95 pivot point. If it approaches the $3.08 resistance level, significant changes may occur.

Previous Close:

$2.94

Open:

$2.8172

24h Volume:

26,863

Market Cap:

$219.27M

Revenue:

Net Income/Loss:

$-4.21M

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+0.00%

1M Performance:

+0.00%

6M Performance:

+137.58%

1Y Performance:

+0.00%

1D Range:

$2.66

$3.05

52W Range:

$0.95

$8.7499

Conduit Pharmaceuticals Inc Stock (CDT) Company Profile

Name

Conduit Pharmaceuticals Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

Address

89 Nexus Way, Grand Cayman

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CDT's Discussions on Twitter

Conduit Pharmaceuticals Inc Stock (CDT) Latest News

Presidio Property Trust, Inc. Announces Earnings for the First Quarter Ended March 31, 2024 - 14.05.2024 - wallstreet:online

wallstreet:online

Presidio Property Trust expands board with new director - Investing.com India

Investing.com India

Presidio Property Trust Reaches Agreement With Zuma Capital Management Appoints Elena Piliptchak to Board of ... - WICZ

WICZ

Presidio Property Trust Reaches Agreement With Zuma Capital Management Appoints Elena ... - WDRB

WDRB

Virtual Event Benzinga Virtual Healthcare Summit 2024 - Benzinga

Benzinga

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub

GlobeNewswire Inc.

Conduit Pharmaceuticals Inc Stock (CDT) Financials Data

Conduit Pharmaceuticals Inc (CDT) Net Income 2024

CDT net income (TTM) was -$4.21 million for the quarter ending September 30, 2023.

Conduit Pharmaceuticals Inc (CDT) Earnings per Share 2024

CDT earnings per share (TTM) was -$0.0548 for the quarter ending September 30, 2023.

Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.